Selected research
Market Structure
Global Analgesic and Anti-inflammatory API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Analgesic and Anti-inflammatory API market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Analgesic and Anti-inflammatory API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Analgesic and Anti-inflammatory API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Analgesic and Anti-inflammatory API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Analgesic and Anti-inflammatory API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Analgesic and Anti-inflammatory API include IOL, Granules India Limited, Mallinckrodt Pharmaceuticals, Novacyl, BASF, Hubei Biocause Group, BBCA Group, Hebei Jiheng Pharmaceutical and Hunan Zhongnan Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
On the production side, the report examines Analgesic and Anti-inflammatory API output, growth rates, and market shares by manufacturer and by region (at regional and country level) for 2021-2026, with forecasts through 2032.
On the consumption side, the report analyzes sales of Analgesic and Anti-inflammatory API by region (regional and country level), company, type, and application for 2021-2026 and provides forecasts through 2032.
The report provides an overview of the global Analgesic and Anti-inflammatory API market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Analgesic and Anti-inflammatory API and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Analgesic and Anti-inflammatory API sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Analgesic and Anti-inflammatory API market size, projected growth trends, production technologies, key applications, and end-use industries.
Analgesic and Anti-inflammatory API Segment by Company
IOL
Granules India Limited
Mallinckrodt Pharmaceuticals
Novacyl
BASF
Hubei Biocause Group
BBCA Group
Hebei Jiheng Pharmaceutical
Hunan Zhongnan Pharmaceutical
Hebei Jingye Medical Technology
Anqiu Lu'an Pharmaceutical
Xinhua Pharm
Zhejiang Kangle Pharmaceutical
Analgesic and Anti-inflammatory API Segment by Type
Dexibuprofen
Diclofenac
Paracetamol
Naproxen
Ibuprofen
Oxaprozin
Aspirin
Others
Analgesic and Anti-inflammatory API Segment by Application
Adults
Children
Analgesic and Anti-inflammatory API Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Analgesic and Anti-inflammatory API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Analgesic and Anti-inflammatory API and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Analgesic and Anti-inflammatory API.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Analgesic and Anti-inflammatory API market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Analgesic and Anti-inflammatory API industry.
Chapter 3: Detailed analysis of Analgesic and Anti-inflammatory API market competition landscape. Including Analgesic and Anti-inflammatory API manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 7: Production/Production Value of Analgesic and Anti-inflammatory API by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 8: Consumption of Analgesic and Anti-inflammatory API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Dexibuprofen
- Diclofenac
- Paracetamol
- Naproxen
- Ibuprofen
- Oxaprozin
- Aspirin
- Others
Applications
- Adults
- Children
Companies covered
- IOL
- Granules India Limited
- Mallinckrodt Pharmaceuticals
- Novacyl
- BASF
- Hubei Biocause Group
- BBCA Group
- Hebei Jiheng Pharmaceutical
- Hunan Zhongnan Pharmaceutical
- Hebei Jingye Medical Technology
- Anqiu Lu'an Pharmaceutical
- Xinhua Pharm
- Zhejiang Kangle Pharmaceutical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Analgesic and Anti-inflammatory API Production Value Estimates and Forecasts (2021-2032)
- 1.2.2 Global Analgesic and Anti-inflammatory API Production Capacity Estimates and Forecasts (2021-2032)
- 1.2.3 Global Analgesic and Anti-inflammatory API Production Estimates and Forecasts (2021-2032)
- 1.2.4 Global Analgesic and Anti-inflammatory API Market Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Global Analgesic and Anti-inflammatory API Market Dynamics
- 2.1 Analgesic and Anti-inflammatory API Industry Trends
- 2.2 Analgesic and Anti-inflammatory API Industry Drivers
- 2.3 Analgesic and Anti-inflammatory API Industry Opportunities and Challenges
- 2.4 Analgesic and Anti-inflammatory API Industry Restraints
3 Analgesic and Anti-inflammatory API Market by Manufacturers
- 3.1 Global Analgesic and Anti-inflammatory API Production Value by Manufacturers (2021-2026)
- 3.2 Global Analgesic and Anti-inflammatory API Production by Manufacturers (2021-2026)
- 3.3 Global Analgesic and Anti-inflammatory API Average Price by Manufacturers (2021-2026)
- 3.4 Global Analgesic and Anti-inflammatory API Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Analgesic and Anti-inflammatory API Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Analgesic and Anti-inflammatory API Manufacturers, Product Type & Application
- 3.7 Global Analgesic and Anti-inflammatory API Manufacturers Established Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Analgesic and Anti-inflammatory API Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Analgesic and Anti-inflammatory API Players Market Share by Production Value in 2025
- 3.8.3 2025 Analgesic and Anti-inflammatory API Tier 1, Tier 2, and Tier 3
4 Analgesic and Anti-inflammatory API Market by Type
- 4.1 Analgesic and Anti-inflammatory API Type Introduction
- 4.1.1 Dexibuprofen
- 4.1.2 Diclofenac
- 4.1.3 Paracetamol
- 4.1.4 Naproxen
- 4.1.5 Ibuprofen
- 4.1.6 Oxaprozin
- 4.1.7 Aspirin
- 4.1.8 Others
- 4.2 Global Analgesic and Anti-inflammatory API Production by Type
- 4.2.1 Global Analgesic and Anti-inflammatory API Production by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Analgesic and Anti-inflammatory API Production by Type (2021-2032)
- 4.2.3 Global Analgesic and Anti-inflammatory API Production Market Share by Type (2021-2032)
- 4.3 Global Analgesic and Anti-inflammatory API Production Value by Type
- 4.3.1 Global Analgesic and Anti-inflammatory API Production Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Analgesic and Anti-inflammatory API Production Value by Type (2021-2032)
- 4.3.3 Global Analgesic and Anti-inflammatory API Production Value Market Share by Type (2021-2032)
5 Analgesic and Anti-inflammatory API Market by Application
- 5.1 Analgesic and Anti-inflammatory API Application Introduction
- 5.1.1 Adults
- 5.1.2 Children
- 5.2 Global Analgesic and Anti-inflammatory API Production by Application
- 5.2.1 Global Analgesic and Anti-inflammatory API Production by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Analgesic and Anti-inflammatory API Production by Application (2021-2032)
- 5.2.3 Global Analgesic and Anti-inflammatory API Production Market Share by Application (2021-2032)
- 5.3 Global Analgesic and Anti-inflammatory API Production Value by Application
- 5.3.1 Global Analgesic and Anti-inflammatory API Production Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Analgesic and Anti-inflammatory API Production Value by Application (2021-2032)
- 5.3.3 Global Analgesic and Anti-inflammatory API Production Value Market Share by Application (2021-2032)
6 Company Profiles
- 6.1 IOL
- 6.1.1 IOL Company Information
- 6.1.2 IOL Business Overview
- 6.1.3 IOL Analgesic and Anti-inflammatory API Production, Value and Gross Margin (2021-2026)
- 6.1.4 IOL Analgesic and Anti-inflammatory API Product Portfolio
- 6.1.5 IOL Recent Developments
- 6.2 Granules India Limited
- 6.2.1 Granules India Limited Company Information
- 6.2.2 Granules India Limited Business Overview
- 6.2.3 Granules India Limited Analgesic and Anti-inflammatory API Production, Value and Gross Margin (2021-2026)
- 6.2.4 Granules India Limited Analgesic and Anti-inflammatory API Product Portfolio
- 6.2.5 Granules India Limited Recent Developments
- 6.3 Mallinckrodt Pharmaceuticals
- 6.3.1 Mallinckrodt Pharmaceuticals Company Information
- 6.3.2 Mallinckrodt Pharmaceuticals Business Overview
- 6.3.3 Mallinckrodt Pharmaceuticals Analgesic and Anti-inflammatory API Production, Value and Gross Margin (2021-2026)
- 6.3.4 Mallinckrodt Pharmaceuticals Analgesic and Anti-inflammatory API Product Portfolio
- 6.3.5 Mallinckrodt Pharmaceuticals Recent Developments
- 6.4 Novacyl
- 6.4.1 Novacyl Company Information
- 6.4.2 Novacyl Business Overview
- 6.4.3 Novacyl Analgesic and Anti-inflammatory API Production, Value and Gross Margin (2021-2026)
- 6.4.4 Novacyl Analgesic and Anti-inflammatory API Product Portfolio
- 6.4.5 Novacyl Recent Developments
- 6.5 BASF
- 6.5.1 BASF Company Information
- 6.5.2 BASF Business Overview
- 6.5.3 BASF Analgesic and Anti-inflammatory API Production, Value and Gross Margin (2021-2026)
- 6.5.4 BASF Analgesic and Anti-inflammatory API Product Portfolio
- 6.5.5 BASF Recent Developments
- 6.6 Hubei Biocause Group
- 6.6.1 Hubei Biocause Group Company Information
- 6.6.2 Hubei Biocause Group Business Overview
- 6.6.3 Hubei Biocause Group Analgesic and Anti-inflammatory API Production, Value and Gross Margin (2021-2026)
- 6.6.4 Hubei Biocause Group Analgesic and Anti-inflammatory API Product Portfolio
- 6.6.5 Hubei Biocause Group Recent Developments
- 6.7 BBCA Group
- 6.7.1 BBCA Group Company Information
- 6.7.2 BBCA Group Business Overview
- 6.7.3 BBCA Group Analgesic and Anti-inflammatory API Production, Value and Gross Margin (2021-2026)
- 6.7.4 BBCA Group Analgesic and Anti-inflammatory API Product Portfolio
- 6.7.5 BBCA Group Recent Developments
- 6.8 Hebei Jiheng Pharmaceutical
- 6.8.1 Hebei Jiheng Pharmaceutical Company Information
- 6.8.2 Hebei Jiheng Pharmaceutical Business Overview
- 6.8.3 Hebei Jiheng Pharmaceutical Analgesic and Anti-inflammatory API Production, Value and Gross Margin (2021-2026)
- 6.8.4 Hebei Jiheng Pharmaceutical Analgesic and Anti-inflammatory API Product Portfolio
- 6.8.5 Hebei Jiheng Pharmaceutical Recent Developments
- 6.9 Hunan Zhongnan Pharmaceutical
- 6.9.1 Hunan Zhongnan Pharmaceutical Company Information
- 6.9.2 Hunan Zhongnan Pharmaceutical Business Overview
- 6.9.3 Hunan Zhongnan Pharmaceutical Analgesic and Anti-inflammatory API Production, Value and Gross Margin (2021-2026)
- 6.9.4 Hunan Zhongnan Pharmaceutical Analgesic and Anti-inflammatory API Product Portfolio
- 6.9.5 Hunan Zhongnan Pharmaceutical Recent Developments
- 6.10 Hebei Jingye Medical Technology
- 6.10.1 Hebei Jingye Medical Technology Company Information
- 6.10.2 Hebei Jingye Medical Technology Business Overview
- 6.10.3 Hebei Jingye Medical Technology Analgesic and Anti-inflammatory API Production, Value and Gross Margin (2021-2026)
- 6.10.4 Hebei Jingye Medical Technology Analgesic and Anti-inflammatory API Product Portfolio
- 6.10.5 Hebei Jingye Medical Technology Recent Developments
- 6.11 Anqiu Lu'an Pharmaceutical
- 6.11.1 Anqiu Lu'an Pharmaceutical Company Information
- 6.11.2 Anqiu Lu'an Pharmaceutical Business Overview
- 6.11.3 Anqiu Lu'an Pharmaceutical Analgesic and Anti-inflammatory API Production, Value and Gross Margin (2021-2026)
- 6.11.4 Anqiu Lu'an Pharmaceutical Analgesic and Anti-inflammatory API Product Portfolio
- 6.11.5 Anqiu Lu'an Pharmaceutical Recent Developments
- 6.12 Xinhua Pharm
- 6.12.1 Xinhua Pharm Company Information
- 6.12.2 Xinhua Pharm Business Overview
- 6.12.3 Xinhua Pharm Analgesic and Anti-inflammatory API Production, Value and Gross Margin (2021-2026)
- 6.12.4 Xinhua Pharm Analgesic and Anti-inflammatory API Product Portfolio
- 6.12.5 Xinhua Pharm Recent Developments
- 6.13 Zhejiang Kangle Pharmaceutical
- 6.13.1 Zhejiang Kangle Pharmaceutical Company Information
- 6.13.2 Zhejiang Kangle Pharmaceutical Business Overview
- 6.13.3 Zhejiang Kangle Pharmaceutical Analgesic and Anti-inflammatory API Production, Value and Gross Margin (2021-2026)
- 6.13.4 Zhejiang Kangle Pharmaceutical Analgesic and Anti-inflammatory API Product Portfolio
- 6.13.5 Zhejiang Kangle Pharmaceutical Recent Developments
7 Global Analgesic and Anti-inflammatory API Production by Region
- 7.1 Global Analgesic and Anti-inflammatory API Production by Region: 2021 VS 2025 VS 2032
- 7.2 Global Analgesic and Anti-inflammatory API Production by Region (2021-2032)
- 7.2.1 Global Analgesic and Anti-inflammatory API Production by Region (2021-2026)
- 7.2.2 Global Analgesic and Anti-inflammatory API Production Forecast by Region (2027-2032)
- 7.3 Global Analgesic and Anti-inflammatory API Production by Region: 2021 VS 2025 VS 2032
- 7.4 Global Analgesic and Anti-inflammatory API Production Value by Region (2021-2032)
- 7.4.1 Global Analgesic and Anti-inflammatory API Production Value by Region (2021-2026)
- 7.4.2 Global Analgesic and Anti-inflammatory API Production Value by Region (2027-2032)
- 7.5 Global Analgesic and Anti-inflammatory API Market Price Analysis by Region (2021-2032)
- 7.6 Regional Production Value Trends (2021-2032)
- 7.6.1 North America Analgesic and Anti-inflammatory API Production Value (2021-2032)
- 7.6.2 Europe Analgesic and Anti-inflammatory API Production Value (2021-2032)
- 7.6.3 Asia-Pacific Analgesic and Anti-inflammatory API Production Value (2021-2032)
- 7.6.4 South America Analgesic and Anti-inflammatory API Production Value (2021-2032)
- 7.6.5 Middle East & Africa Analgesic and Anti-inflammatory API Production Value (2021-2032)
8 Global Analgesic and Anti-inflammatory API Consumption by Region
- 8.1 Global Analgesic and Anti-inflammatory API Consumption by Region: 2021 VS 2025 VS 2032
- 8.2 Global Analgesic and Anti-inflammatory API Consumption by Region (2021-2032)
- 8.2.1 Global Analgesic and Anti-inflammatory API Consumption by Region (2021-2026)
- 8.2.2 Global Analgesic and Anti-inflammatory API Consumption by Region (2027-2032)
- 8.3 North America
- 8.3.1 North America Analgesic and Anti-inflammatory API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3.2 North America Analgesic and Anti-inflammatory API Consumption by Country (2021-2032)
- 8.3.3 U.S.
- 8.3.4 Canada
- 8.3.5 Mexico
- 8.4 Europe
- 8.4.1 Europe Analgesic and Anti-inflammatory API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.4.2 Europe Analgesic and Anti-inflammatory API Consumption by Country (2021-2032)
- 8.4.3 Germany
- 8.4.4 France
- 8.4.5 U.K.
- 8.4.6 Italy
- 8.4.7 Netherlands
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Analgesic and Anti-inflammatory API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.5.2 Asia Pacific Analgesic and Anti-inflammatory API Consumption by Country (2021-2032)
- 8.5.3 China
- 8.5.4 Japan
- 8.5.5 South Korea
- 8.5.6 Southeast Asia
- 8.5.7 India
- 8.5.8 Australia
- 8.6 South America
- 8.6.1 South America Analgesic and Anti-inflammatory API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.6.2 South America Analgesic and Anti-inflammatory API Consumption by Country (2021-2032)
- 8.6.3 Brazil
- 8.6.4 Argentina
- 8.6.5 Chile
- 8.6.6 Colombia
- 8.7 Middle East & Africa
- 8.7.1 Middle East & Africa Analgesic and Anti-inflammatory API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.7.2 Middle East & Africa Analgesic and Anti-inflammatory API Consumption by Country (2021-2032)
- 8.7.3 Egypt
- 8.7.4 South Africa
- 8.7.5 Israel
- 8.7.6 Türkiye
- 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
- 9.1 Analgesic and Anti-inflammatory API Value Chain Analysis
- 9.1.1 Analgesic and Anti-inflammatory API Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Analgesic and Anti-inflammatory API Production Mode & Process
- 9.2 Analgesic and Anti-inflammatory API Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Analgesic and Anti-inflammatory API Distributors
- 9.2.3 Analgesic and Anti-inflammatory API Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst